Sionna Therapeutics to Present at the Guggenheim Securities Emerging Outlook: Biotech Summit 2026
Sionna Therapeutics to Present at the Guggenheim Securities Emerging Outlook: Biotech Summit 2026 GlobeNewswire February 04, 2026 WALTHAM, Mass., Feb. 04, 2026 (GLOBE NEWSWIRE) — Sionna Therapeutics, Inc. (Nasdaq: SION), a clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment paradigm for cystic fibrosis (CF) by developing novel medicines that normalize the function […]